KR20240044452A - 신규한 스피로피롤리딘 유래 항바이러스제 - Google Patents

신규한 스피로피롤리딘 유래 항바이러스제 Download PDF

Info

Publication number
KR20240044452A
KR20240044452A KR1020247006429A KR20247006429A KR20240044452A KR 20240044452 A KR20240044452 A KR 20240044452A KR 1020247006429 A KR1020247006429 A KR 1020247006429A KR 20247006429 A KR20247006429 A KR 20247006429A KR 20240044452 A KR20240044452 A KR 20240044452A
Authority
KR
South Korea
Prior art keywords
optionally substituted
compound
mmol
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247006429A
Other languages
English (en)
Korean (ko)
Inventor
루이차오 센
용 허
수에차오 싱
매튜 씨 로즈
조셉 디. 파나레스
사무엘 바틀렛
웨이 리
후이 카오
지아준 즈항
시아오웬 펭
구오치앙 왕
야트 순 올
Original Assignee
이난타 파마슈티칼스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/479,248 external-priority patent/US11325916B1/en
Application filed by 이난타 파마슈티칼스, 인코포레이티드 filed Critical 이난타 파마슈티칼스, 인코포레이티드
Publication of KR20240044452A publication Critical patent/KR20240044452A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020247006429A 2021-07-29 2022-04-14 신규한 스피로피롤리딘 유래 항바이러스제 Pending KR20240044452A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163227206P 2021-07-29 2021-07-29
US63/227,206 2021-07-29
US17/479,248 2021-09-20
US17/479,248 US11325916B1 (en) 2021-07-29 2021-09-20 Spiropyrrolidine derived antiviral agents
US202263324367P 2022-03-28 2022-03-28
US63/324,367 2022-03-28
PCT/US2022/024772 WO2023009187A1 (en) 2021-07-29 2022-04-14 Novel spiropyrrolidine derived antiviral agents

Publications (1)

Publication Number Publication Date
KR20240044452A true KR20240044452A (ko) 2024-04-04

Family

ID=85087186

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247006429A Pending KR20240044452A (ko) 2021-07-29 2022-04-14 신규한 스피로피롤리딘 유래 항바이러스제

Country Status (8)

Country Link
EP (1) EP4376834A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024529476A (cg-RX-API-DMAC7.html)
KR (1) KR20240044452A (cg-RX-API-DMAC7.html)
AU (1) AU2022319598A1 (cg-RX-API-DMAC7.html)
CA (1) CA3173702A1 (cg-RX-API-DMAC7.html)
IL (1) IL310246A (cg-RX-API-DMAC7.html)
MX (1) MX2024001377A (cg-RX-API-DMAC7.html)
WO (1) WO2023009187A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7559223B2 (ja) 2020-08-24 2024-10-01 ギリアード サイエンシーズ, インコーポレイテッド リン脂質化合物及びその使用
TWI925033B (zh) 2020-10-16 2026-05-11 美商基利科學股份有限公司 磷脂化合物及其用途
WO2023283256A1 (en) 2021-07-09 2023-01-12 Aligos Therapeutics, Inc. Anti-viral compounds
AU2023303408A1 (en) 2022-07-06 2024-12-19 Aligos Therapeutics, Inc. Anti-viral compounds
EP4612156A1 (en) * 2022-11-02 2025-09-10 Aligos Therapeutics, Inc. Anti-viral compounds
CN119139307B (zh) * 2023-12-29 2025-09-23 上海柯君医药科技有限公司 螺环类化合物在制备3CLpro蛋白酶抑制剂或药物中的用途
WO2025221657A1 (en) * 2024-04-15 2025-10-23 Aligos Therapeutics, Inc. Anti-viral compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061714A2 (en) * 2004-12-09 2006-06-15 Pfizer Inc. Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
US8222288B2 (en) * 2006-08-30 2012-07-17 The Regents Of The University Of Michigan Small molecule inhibitors of MDM2 and the uses thereof
CA2661354C (en) * 2006-08-30 2012-12-18 The Regents Of The University Of Michigan New small molecule inhibitors of mdm2 and the uses thereof
US8575208B2 (en) * 2007-02-27 2013-11-05 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
UY37381A (es) * 2016-08-30 2018-03-23 Glaxosmithkline Ip No 2 Ltd Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos
US12398147B2 (en) * 2021-05-11 2025-08-26 Enanta Pharmaceuticals, Inc. Macrocyclic spiropyrrolidine derived antiviral agents
US11325916B1 (en) * 2021-07-29 2022-05-10 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
WO2023086400A1 (en) * 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2023125825A1 (en) * 2021-12-29 2023-07-06 Shanghai Curegene Pharmaceutical Co., Ltd. Anticoronviral compounds and compositions and uses thereof

Also Published As

Publication number Publication date
EP4376834A4 (en) 2025-06-18
WO2023009187A1 (en) 2023-02-02
AU2022319598A1 (en) 2024-02-08
EP4376834A1 (en) 2024-06-05
CA3173702A1 (en) 2023-01-29
IL310246A (en) 2024-03-01
JP2024529476A (ja) 2024-08-06
MX2024001377A (es) 2024-03-08

Similar Documents

Publication Publication Date Title
US12479854B2 (en) Spiropyrrolidine derived antiviral agents
JP7795521B2 (ja) 抗ウイルス剤としての官能化ペプチド
AU2021381437B2 (en) Novel spiropyrrolidine derived antiviral agents
US12540141B2 (en) Spiropyrrolidine derived antiviral agents
US11325916B1 (en) Spiropyrrolidine derived antiviral agents
US12145942B2 (en) Spiropyrrolidine derived antiviral agents
WO2022109360A1 (en) Novel spiropyrrolidine derived antiviral agents
EP4196117A1 (en) Functionalized peptides as antiviral agents
US20230115107A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2023091561A1 (en) Novel spiropyrrolidine derived antiviral agents
AU2022319598A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2023086350A1 (en) Alkyne-containing antiviral agents
WO2023086352A1 (en) Novel spiropyrrolidine derived antiviral agents
WO2023107417A1 (en) Heterocyclic antiviral agents
WO2023003610A1 (en) Novel spiropyrrolidine derived antiviral agents
EA050743B1 (ru) Новые противовирусные агенты на основе производных спиропирролидина
CN118043045A (zh) 新型螺吡咯烷衍生的抗病毒药物
HK40071048A (en) Novel spiropyrrolidine derived antiviral agents

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000